References
Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP report 1. Arch Ophthalmol 1999;117:1329–1345.
Schmidt-Erfurth UM, Pruente C. Management of neovascular age-related macular degeneration. Prog Retin Eye Res 2007;26:437–451.
Treatment of age-related macular degeneration with photodynamic therapy and verteporfin in photodynamic therapy study groups. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1. Am J Ophthalmol 2003;136:407–418.
Gomi F, Sawa M, Mitarai K, Tsujikawa M, Tano Y. Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography. Graefes Arch Clin Exp Ophthalmol 2007;245:1421–1427.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Imasawa, M., Tsumura, T., Kikuchi, T. et al. Humphrey perimetry as a predictor of visual improvement after photodynamic therapy. Jpn J Ophthalmol 53, 281–282 (2009). https://doi.org/10.1007/s10384-008-0644-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-008-0644-5